Company news
Voyageur Pharmaceuticals Ltd news in 2024
Voyageur Pharmaceuticals Ltd's news releases, calls and decks from 2024, newest first.
Voyageur Pharmaceuticals Ltd. Signs Letter of Intent with Global Contrast Imaging Company to Expand Market Reach and Product Portfolio
December 20, 2024
Voyageur Announces Closing of Final Tranche of Private Placement
December 18, 2024
Voyageur Announces Closing of First Tranche of Private Placement
December 3, 2024
Voyageur Announces Extension to Complete Proposed Private Placement
November 26, 2024
Voyageur Announces Proposed Private Placement
October 17, 2024
Voyageur Pharmaceuticals Grants Stock Options
September 25, 2024
Voyageur Pharmaceuticals Strengthens Leadership Team with Strategic Appointment of Dr. Ibrahim Hashmi as VP of Business Development
September 24, 2024
Voyageur Pharmaceuticals Appoints Dr. Iryna Saranchova as Chief Science Officer, Enhancing the Company's Research and Innovation Leadership
September 17, 2024
Voyageur Introduces Five New Barium Contrast Formulations Setting New Standards in Medical Imaging Industry
September 5, 2024
Voyageur Pharmaceuticals and Rain Cage Carbon Partner to Develop Advanced Radiology Contrast Agents
June 11, 2024
Testing to Begin of Radiology Endohedral Fullerenes, a Milestone in Nanotechnology & Drug Development
June 11, 2024
Voyageur Pharmaceuticals Secures $1.9 Million Sales Contract for Latin America
May 28, 2024
Voyageur Pharmaceuticals Ltd Secures USD $1.9 Million Sales Contract for SmoothX 2% Barium Contrast
May 28, 2024
Voyageur Pharmaceuticals Ltd Grants Deferred Share Units Compensation to Independent Directors
April 3, 2024
Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options
March 26, 2024
Voyageur Achieves Milestone with Rain Cage Royalty Agreement for Sustainable Carbon Drug Development
March 13, 2024
Voyageur Pharmaceuticals and API Forge Alliance for Carbon-Based Imaging Drug Advancement
March 4, 2024
Voyageur Pharmaceuticals Ltd. Announces Closing of Private Placement
March 1, 2024
Voyageur Pharmaceuticals Ltd. Announces Private Placement
January 16, 2024